SCHEMBL9119656

SCHEMBL9119656

CC(C)Cc1ccccc1[C@H](C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.49
PTGS1 P23219 5/20 0.49
LMNA P02545 2/20 0.49
CYP2C9 P11712 2/20 0.49
AKR1C3 P42330 2/20 0.49
CXCR1 P25024 2/20 0.49
CXCR2 P25025 2/20 0.49
CXCL8 P10145 2/20 0.49
ALB P02768 1/20 0.49
ESR1 P03372 1/20 0.49
ALOX5 P09917 1/20 0.49
RARB P10826 1/20 0.49
ADRB3 P13945 1/20 0.49
NFKB1 P19838 1/20 0.49
HTR2A P28223 1/20 0.49
NR1I3 Q14994 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
TSHR P16473 1/20 0.49
AKR1C2 P52895 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1394339 1.00 PTGS2 (0.49) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL3155111 1.00 PTGS2 (0.49) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL4483212 0.89 GABRA1 (0.47) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL4480628 0.89 GABRA1 (0.47) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL5016325 0.89 GABRA1 (0.47) PTGS2PTGS1LMNACYP2C9AKR1C3
Ibuprofen SCHEMBL1891683 0.88 PTGS2 (0.71) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL5960824 0.86 GABRA1 (0.42) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL5017117 0.86 GABRA1 (0.42) PTGS2PTGS1LMNACYP2C9AKR1C3
SCHEMBL10429886 0.86 CYP2D6 (0.47) PTGS2PTGS1CYP2C9CXCL8MMP1
SCHEMBL5983552 0.85 PTGS2 (0.46) PTGS2PTGS1LMNAAKR1C3CXCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0398288-B1 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids PUETTER MEDICE CHEM PHARM (DE) 1995-10-18 EP disclosed
EP-0641304-A1 STEREO-SELECTIVE SYNTHESIS OF 2-ARYL-PROPIONIC ACIDS OF HIGH OPTICAL PURITY BY USING CHIRAL OXAZOLINES CHEMISCH BIOTECHNOLOGISCHE LABORATORIEN GMBH (DE) 1995-03-08 EP disclosed
US-5380927-A Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1995-01-10 US disclosed
US-5266723-A Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids MEDICE, LTD., CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1993-11-30 US disclosed
US-5248815-A STEREO-SELECTIVE SYNTHESIS OF 2-ARYL-PROPIONIC ACIDS OF HIGH OPTICAL PURITY BY USING CHIRAL OXAZOLINES PARADIES HENRICH H (DE) 1993-09-28 US disclosed
WO-1993013046-A1 STEREO-SELECTIVE SYNTHESIS OF 2-ARYL-PROPIONIC ACIDS OF HIGH OPTICAL PURITY BY USING CHIRAL OXAZOLINES KUNICHEM, INC. (US) 1993-07-08 WO disclosed
EP-0398288-A2 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) 1990-11-22 EP disclosed
EP-0158913-A2 Process for the preparation of optically active alpha-arylalkanoic acids and intermediates thereof ZAMBON S.p.A. (IT) 1985-10-23 EP disclosed